Get Your Personalized Supplement StackSupplement Stack Quiz

Melatonin Extended Release

Also known as: Melatonin, N-acetyl-5-methoxytryptamine, Hormone of darkness, Pineal hormone

Overview

Melatonin is a naturally occurring hormone primarily produced by the pineal gland in response to darkness. It plays a crucial role in regulating circadian rhythms and sleep-wake cycles. As a supplement, melatonin is used to treat various sleep disorders, including insomnia, delayed sleep phase syndrome, and jet lag. Extended-release formulations are designed to mimic the body's natural melatonin secretion pattern, providing a sustained release over several hours, which may be particularly beneficial for maintaining sleep throughout the night. Research indicates that melatonin is effective in reducing sleep onset latency and improving overall sleep quality. It is available in various forms, including immediate-release and extended-release tablets, capsules, and liquids. While generally safe, it's important to adhere to recommended dosages and be aware of potential side effects and drug interactions.

Benefits

Melatonin supplementation has been shown to significantly reduce sleep onset latency, with studies indicating a dose-response effect peaking around 4 mg/day. It also modestly increases total sleep time, with subjective measures showing an average increase of about 12 minutes. Extended-release formulations are particularly effective for improving sleep maintenance by providing a sustained release of melatonin throughout the night. Beyond sleep regulation, some research suggests that melatonin may reduce blood pressure and improve cardiovascular risk markers. It is particularly beneficial for individuals with primary sleep disorders, such as insomnia and circadian rhythm disruptions. The effects of melatonin are typically observed within a short period, with some evidence supporting its efficacy for longer-term use.

How it works

Melatonin primarily works by interacting with MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN) of the hypothalamus, which is the brain's central circadian pacemaker. By binding to these receptors, melatonin helps to regulate the sleep-wake cycle and promote feelings of sleepiness. Additionally, melatonin exhibits antioxidant and anti-inflammatory properties, which may contribute to its overall health benefits. The absorption of oral melatonin is rapid, but extended-release formulations are designed to slow down this absorption, maintaining a more consistent plasma concentration over a longer period. This sustained release helps to improve sleep maintenance throughout the night.

Side effects

Melatonin is generally well-tolerated, but some side effects can occur. Common side effects include drowsiness, headache, and dizziness. Less common side effects may include nausea and irritability. Rare side effects, such as allergic reactions and vivid dreams, have also been reported. Melatonin can interact with certain medications, including anticoagulants, immunosuppressants, and CNS depressants. Caution is advised for individuals who are pregnant, breastfeeding, or have autoimmune diseases due to limited safety data in these populations. While generally safe for children and the elderly, appropriate dosing adjustments are necessary. It's important to adhere to recommended dosages, as higher doses may increase the risk of side effects.

Dosage

The minimum effective dose of melatonin for sleep onset effects is around 0.3 to 0.5 mg, while extended-release formulations often use dosages between 2 and 5 mg. Meta-analyses suggest that peak efficacy for sleep promotion is achieved at approximately 4 mg/day. Doses up to 10 mg/day have been studied with good safety, but higher doses may increase the risk of side effects. Melatonin should be taken 30 to 60 minutes before bedtime, with timing potentially optimized based on individual circadian phase. Extended-release formulations are preferred for sleep maintenance issues, while immediate-release formulations are better suited for sleep onset difficulties. Food may delay the absorption of immediate-release melatonin, but extended-release formulations mitigate this effect. No specific cofactors are required for melatonin to be effective.

FAQs

Is extended-release melatonin more effective than immediate-release?

Extended-release melatonin is better for sleep maintenance by sustaining melatonin levels overnight, while immediate-release primarily reduces sleep onset latency.

Is melatonin safe for long-term use?

Evidence supports short- to medium-term safety; long-term safety data are limited but currently reassuring. Consult a healthcare provider for extended use.

How soon will I see results?

Effects on sleep onset can be seen within days; improvements in total sleep time may take longer with consistent use.

Can melatonin cause dependency?

No evidence supports physical dependency or withdrawal symptoms associated with melatonin use at recommended dosages.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/35388609/ – This meta-analysis evaluated the impact of controlled-release melatonin on blood pressure and cardiovascular risk markers. It found reductions in asleep blood pressure, suggesting potential cardiovascular benefits alongside sleep improvements. The included RCTs were well-controlled with statistically significant outcomes.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3656905/ – This meta-analysis included multiple RCTs with over 1,200 subjects, showing melatonin significantly reduces sleep onset latency and improves subjective total sleep time by approximately 12 minutes. Objective total sleep time improvements were not significant. Limitations include heterogeneity in measures and short trial durations.
https://onlinelibrary.wiley.com/doi/10.1111/jpi.12782 – This systematic review analyzed RCTs with low risk of bias, finding no significant increase in serious adverse events or withdrawals due to adverse events at higher doses of melatonin. Mild side effects such as drowsiness and headache were more common but generally well tolerated. The review highlighted the need for better long-term safety data.
https://onlinelibrary.wiley.com/doi/10.1111/jpi.12985 – This recent meta-analysis demonstrated a dose-dependent effect of melatonin on reducing sleep onset latency and increasing total sleep time, peaking at 4 mg/day. It included RCTs with adequate sample sizes and robust methodology, confirming optimal dosing strategies for sleep benefits.
https://www.cda-amc.ca/sites/default/files/pdf/htis/2022/RC1422%20Melatonin%20for%20Insomnia%20Final.pdf – This review provides a comprehensive overview of melatonin's efficacy and safety for treating insomnia. It summarizes key findings from clinical trials and meta-analyses, highlighting its benefits for sleep onset and maintenance. The review also addresses potential side effects and drug interactions, offering practical guidance for healthcare professionals.